4%%%%%
.png)
.png)
.png)
.png)
Inkomba
Ukubonakala:Lo mkhiqizo awunambala owuketshezi ophuzi noma ophuzi oluhlaza ophuzi.
Isenzo samakhemisi:PharmacodynamicGelamycinIngabe i-antibooside ye-aminoglycoside enomphumela we-antibacterial kuma-bacterium ahlukahlukene angenamikhawulo (njenge-Escherhichia Coli, uKlebsicha, amaprotheni, njll.) noStaphylococcus aureus (kufaka phakathi izingqinamba ze-β-lactamase Iningi le-COCCI (i-streptococcus pyogenes, i-pneumococcus, i-streptococcus fiaecalis, njll.), Amagciwane anaerobic (ama-bacteriobic noma i-borvencuium), i-mycobactertsium tuberculoum, i-ricktsia kanye nesikhunta ayamelana nalo mkhiqizo.
Pharmacokinetics:Ukutholwa kushesha futhi kuqedile ngemuva komjovo we-intramuscular. Ukugxila kwe-peak kufinyelelwa ngaphakathi kwehora le-0.5 kuya ku-1. I-Bioavailability idlula ama-90% ngomjovo ongaphansi noma we-intramuscular. I-excrekwe ikakhulukazi ngokuhlunga kwe-glomerular kanye nama-akhawunti ama-40% kuya ku-80% womthamo olawulwa. Ukuqedwa kwe-Half-Life ngemuva komjovo we-intramuscular kungamahora angama-3.8 kuya kuma-3.3 amahora angama-2,2 kuya ku-3.5 emaphepheni, amakati angu-2,5 ezinjeni, nama-buffaloes, nezinkomo, nezimbuzi zobisi.
Ukusebenzisana kwezidakamizwa:
(1) Inhlanganisela yeGedaCycin nge-tetracycline ne-erythromycin kungenzeka kube nomphumela wokuphikisana.
(2) Ngokuhambisana nama-cephalosporins, dextran, ama-diuretics anamandla (afana ne-furosemide, njll.), Ne-Erythromycin, i-ototoxicity yalo mkhiqizo ingathuthukiswa.
.
Isenzo nokusetshenziswa
Ama-aminoglycoside antibiotic. Ngezifo ezingezinhle ze-gram nezobuhle.
Umthamo nokuphatha
(1) Ototoxicity. Imvamisa kubangela ukulimala kwe-vestibular endlebeni, okungakhuphuka ngokuqongelelwa kwezidakamizwa ezilawulwa ngokuqhubekayo ngendlela ethembele umthamo.
(2) ukusabela komzimba ngezikhathi ezithile. Amakati azwela kakhulu, ahlala angenza isicanucanu, ukugabha, ama-salivation kanye ne-ataxia.
(3) Imithamo ephezulu ingadala ukukhiqizwa kwe-neuromuscular. Ukufa ngengozi kuvame ukwenzeka ngemuva kwe-anesthesia ejwayelekile yezinqubo zokuhlinzwa ezinjeni nasemakati, kuhlanganiswe ne-penicillin ukuvikela ukutheleleka.
(4) kungadala ukungaguquki kwe-nephrotoxicity.
Izinyathelo zokuzivikela
.
(2) Ngokuhambisana ne-penicillin, lo mkhiqizo unomphumela we-synertistic ku-streptococci.
(3) Inokucindezelwa okuphefumula futhi akufanele ifakwe ngaphakathi.
(4) Ukuphikiswa kungenzeka kwenzeke ngokuhlanganiswa ne-tetracycline ne-erythromycin.
(5) Inhlanganisela ne-cephalosporins ingakhulisa i-nephrotoxicity.
Isikhathi sokuhoxisa
Ingulube, inkomo nezimvu izinsuku ezingama-40.
Ukubeka
Kuvaliwe futhi kugcinwe endaweni epholile emnyama.
UHebei Veyong Pharmaceutical Co, Ltd, wasungulwa ngonyaka ka-2002, etholakala eShijiazhuang City, esifundeni saseHebei, eChina, eduze kwenhloko-dolobha eBeijing. Uyibhizinisi elikhulu lezidakamizwa eliqinisekisiwe le-GMP, nge-R & D, ukukhiqizwa kanye nokuthengiswa kwama-apis wezilwane, amalungiselelo, okuphakelayo okubekiwe kanye nokuphakelwa izengezo. Njengesikhungo sezobuchwepheshe sesifundazwe, uVeyong usungule uhlelo olusha lwe-R & D lwe-New Veterinary Drug, futhi yiwona we-technological annology ebhizinisini elisuselwa kubuchwepheshe, kukhona ochwepheshe bezobuchwepheshe abangama-65. UVeyong unezisekelo ezimbili zokukhiqiza: I-Shijuazhuang kanye ne-Ordos, lapho iShijuazhuange isiza ifaka indawo engu-78,706 m2, i-Oxytetracycline imigqa yokukhiqiza kubandakanya i-ivermectin, i-olytetracycline imigqa yokukhiqiza kubandakanya umjovo, i-bolus, ama-pesticides kanye amagciwane, amahlelo. UVeyong unikeza ama-API, amalungiselelo angaphezu kwe-100 anamalebula, kanye nensizakalo ye-OEM & ODM.
UVeyong unamathela ngokubaluleka okukhulu ekuphathweni kwe-EHS (imvelo, ezempilo kanye nokuphepha), futhi uthole izitifiketi ze-ISO14001 nezi- ohsas180000. UVeyong ubhalwe phansi kumabhizinisi wezimboni asafufusa izimboni esifundazweni saseHebei futhi angaqinisekisa ukunikezwa kwemikhiqizo okuqhubekayo.
UVeyong wasungula uhlelo oluphelele lokuphathwa kwekhwalithi, ethola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APHVMA GMP, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi sadlula ukuhlolwa kwe-US FDA. UVeyong uneqembu eliqeqeshiwe lokurejista, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukuthembela nokusekelwa okuvela kumakhasimende amaningi ngekhwalithi ephezulu yomkhiqizo, insizakalo ephezulu yokuthengisa kanye nokuthengisa okuthengiswayo, ukuphathwa okungathi sína. UVeyong wenze ukubambisana isikhathi eside ngamabhizinisi amaningi ezaziwayo ezingezemikhiqizo athunyelwe eYurophu, eSouth America, eMpumalanga Ephakathi, e-Eshiya, e-ESIA, amazwe angaphezu kwangu-60.
